These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24461644)

  • 41. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM
    Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of food on pharmacokinetics of an inhaled drug: a case study with a VLA-4 antagonist, HMR1031.
    Shah B; Jensen BK; Zhang J; Hunt T; Rohatagi S
    J Clin Pharmacol; 2003 Dec; 43(12):1341-9. PubMed ID: 14615470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac.
    Manvelian G; Daniels S; Gibofsky A
    Postgrad Med; 2012 Jan; 124(1):117-23. PubMed ID: 22314121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of the individual enantiomer S-(+)-ketoprofen after intravenous and oral administration in dogs at two dose levels.
    Serrano-Rodríguez JM; Serrano JM; Rodríguez JM; Machuca MM; Gómez-Villamandos RJ; Navarrete-Calvo R
    Res Vet Sci; 2014 Jun; 96(3):523-5. PubMed ID: 24746290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs.
    Almansa C; Bartrolí J; Belloc J; Cavalcanti FL; Ferrando R; Gómez LA; Ramis I; Carceller E; Merlos M; García-Rafanell J
    J Med Chem; 2004 Oct; 47(22):5579-82. PubMed ID: 15481993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the effects of food on the single-dose pharmacokinetics of trametinib, a first-in-class MEK inhibitor, in patients with cancer.
    Cox DS; Papadopoulos K; Fang L; Bauman J; LoRusso P; Tolcher A; Patnaik A; Pendry C; Orford K; Ouellet D
    J Clin Pharmacol; 2013 Sep; 53(9):946-54. PubMed ID: 23893461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
    Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
    Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imipramine in dogs: A pharmacokinetic study following oral administration under fasted and fed conditions.
    Fadel C; Łebkowska-Wieruszewskac B; Lisowski A; Serih F; Poapolathep A; Čudina N; Giorgi M
    Vet J; 2024 Dec; 308():106250. PubMed ID: 39362400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers.
    Delrat P; Paraire M; Jochemsen R
    Biopharm Drug Dispos; 2002 May; 23(4):151-7. PubMed ID: 12015789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog.
    Toutain PL; Cester CC; Haak T; Laroute V
    J Vet Pharmacol Ther; 2001 Feb; 24(1):43-55. PubMed ID: 11348486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs.
    Giorgi M; Portela DA; Breghi G; Briganti A
    Am J Vet Res; 2012 Oct; 73(10):1650-6. PubMed ID: 23013193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
    Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of the novel COX-2 selective inhibitor vitacoxib in cats: The effects of feeding and dose.
    Wang J; Gong X; Xue J; Zhang S; Li J; Cao X
    J Vet Pharmacol Ther; 2019 May; 42(3):294-299. PubMed ID: 30737806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics, bioavailability, and hemodynamic effects of trazodone after intravenous and oral administration of a single dose to dogs.
    Jay AR; Krotscheck U; Parsley E; Benson L; Kravitz A; Mulligan A; Silva J; Mohammed H; Schwark WS
    Am J Vet Res; 2013 Nov; 74(11):1450-6. PubMed ID: 24168312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs.
    Wang J; Schneider BK; Sun P; Gong X; Qiu J; Li J; Seo YJ; Mochel JP; Cao X
    J Vet Pharmacol Ther; 2019 Sep; 42(5):530-540. PubMed ID: 31369157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs.
    Giorgi M; Meizler A; Mills PC
    Vet J; 2012 Dec; 194(3):309-13. PubMed ID: 22771148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of thalidomide in dogs: can feeding affect it? A preliminary study.
    Pierini A; Sartini I; Giorgi M; Łebkowska-Wieruszewska B; Lisowski A; Poapolathep A; Marchetti V
    J Vet Sci; 2020 Sep; 21(5):e60. PubMed ID: 33016014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.